Finch Therapeutics Group, Inc(NASDAQ:FNCH) 
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that has completed Phase II clinical trial for the t...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-08-22
P
O 11.04
H 11.31
L 11.04
C 11.26
V 2,910
10EMA 11.26
20EMA 11.26
60EMA 11.26
120EMA 11.26
250EMA 11.26